Statement of Operations by Fiscal Year, In Millions USD

FY-15 FY-16 FY-17 FY-18 FY-19
Revenues:
Products and licenses 555.8 573.0 559.0 525.6 510.8
Security subscriptions 318.6 389.9 480.4 542.3 610.3
Software updates and maintenance 755.4 778.5 815.3 848.6 873.7
Total revenues 1,629.8 1,741.4 1,854.7 1,916.5 1,994.8
Operating expenses:
Cost of products and licenses 101.1 105.9 104.2 91.8 90.5
Cost of security subscriptions 7.6 10.8 18.8 17.7 24.6
Cost of Software updates and maintenance 76.9 80.9 85.1 85.5 90.3
Total cost of revenues 185.6 197.6 208.1 195.0 205.4
Research & Development 131.6 158.1 168.6 188.0 213.4
Selling and Marketing 340.2 398.0 411.8 476.8 522.1
General & Administrative 45.2 39.4 41.8 41.6 51.1
Total operating expenses Non-GAAP*
702.6 793.1 830.3 901.4 992.0
Stock-based compensation 76.3 82.7 87.3 89.3 106.7
Amortization of intangible assets & acquisition related expenses and acquisition related costs 11.2 13.1 13.2 11.9 14.3
Restructuring and other acquisition related costs 0.0 0.0 0.0 0.0 0.0
Acquisition related in-process R&D 0.0 0.0 0.0 0.0 0.0
Total operating expenses GAAP 790.1 888.9 930.8 1,002.6 1,113.0
Operating income GAAP 839.7 852.5 923.9 913.9 881.8
Operating income Non-GAAP* 927.2 948.3 1,024.4 1,015.1 1,002.8
Financial income, net 34.1 44.4 47.0 65.1 80.6
Net gain (impairment net of gains) on sale of marketable securities previously impaired 0.0 0.0 0.0 0.0 0.0
Income before taxes GAAP 873.8 896.9 970.9 979.0 962.4
Income before taxes Non-GAAP* 961.3 992.7 1,071.4 1,080.2 1,083.4
Income taxes GAAP 187.9 171.8 168.0 157.5 136.7
Income taxes Non-GAAP* 195.1 174.3 183.4 169.0 150.4
Net income GAAP 685.9 725.1 802.9 821.5 825.7
Net income Non GAAP * 766.2 818.4 888.0 911.2 933.0
Earning Per Share (Diluted) GAAP 3.74 4.18 4.82 5.15 5.43
Earning Per Share (Diluted) Non GAAP * 4.17 4.72 5.33 5.71 6.13
Shares Outstanding (Diluted) 183.6 173.3 166.7 159.4 152.1

* Non GAAP exclude non-cash equity-based compensation charges, amortization of intangible assets and acquisition related expenses, restructuring-related charges, acquisition related in-process R&D, other than temporary impairment of marketable securities, net, and the related tax affects.

This website uses cookies to ensure you get the best experience. Got it, Thanks! MORE INFO